Biomedical applications of gold nanomaterials: Opportunities and challenges

Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology

Volumn 7, Issue 6, 2015, Pages 779-796

  Sasidharan, Abhilash ^a   Monteiro Riviere, Nancy A ^a  

^a KANSAS STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCOMPATIBILITY; DIAGNOSIS; GOLD; MEDICAL APPLICATIONS; MEDICAL IMAGING; MEDICAL NANOTECHNOLOGY; NANOSTRUCTURED MATERIALS;

BIO MEDICAL DIAGNOSTICS; BIOLOGICAL PROPERTIES; BIOLOGICAL SENSING; BIOMEDICAL APPLICATIONS; BIOMEDICAL IMAGING; CLINICAL APPLICATION; PHOTOTHERMAL THERAPY; SURFACE CHARACTERISTICS;

DRUG DELIVERY;

GOLD NANOPARTICLE; BIOMATERIAL; GOLD; IMMUNOGLOBULIN G; METAL NANOPARTICLE;

ARTICLE; BIOCOMPATIBILITY; BIOIMAGING; CELL INTERACTION; DIAGNOSIS; DRUG DELIVERY SYSTEM; GENETIC PROCEDURES; HUMAN; IMAGING; NANOMEDICINE; NANOTOXICOLOGY; NONHUMAN; PHOTODYNAMIC THERAPY; PHOTOTHERAPY; PHOTOTHERMAL THERAPY; PRIORITY JOURNAL; PROCEDURES; RADIOFREQUENCY ABLATION; ANIMAL; BAGG ALBINO MOUSE; CHEMISTRY; DIAGNOSTIC IMAGING; FLUORESCENCE MICROSCOPY; MOUSE; PHOTOCHEMISTRY; PHOTOCHEMOTHERAPY; RAMAN SPECTROMETRY; SURFACE PROPERTY; TRANSMISSION ELECTRON MICROSCOPY; TUMOR CELL LINE;

ANIMALS; BIOCOMPATIBLE MATERIALS; BIOSENSING TECHNIQUES; CELL LINE, TUMOR; DIAGNOSTIC IMAGING; DRUG DELIVERY SYSTEMS; GOLD; HUMANS; IMMUNOGLOBULIN G; METAL NANOPARTICLES; MICE; MICE, INBRED BALB C; MICROSCOPY, ELECTRON, TRANSMISSION; MICROSCOPY, FLUORESCENCE; NANOMEDICINE; PHOTOCHEMISTRY; PHOTOCHEMOTHERAPY; SPECTRUM ANALYSIS, RAMAN; SURFACE PROPERTIES;

EID: 84943736788     PISSN: 19395116     EISSN: 19390041     Source Type: Journal    
DOI: 10.1002/wnan.1341     Document Type: Article

References (140)

1. Kim BYS, Rutka JT, Chan WCW. Nanomedicine. N Engl J Med 2010, 363:2434-2443.
2. Freestone I, Meeks N, Sax M, Higgitt C. The Lycurgus cup-a Roman nanotechnology. Gold Bull 2007, 40:270-277.
3. Antonovych TT. Gold nephropathy. Ann Clin Lab Sci 1981, 11:386-391.
4. Clark P, Tugwell P, Bennet K, Bombardier C, Shea B, Wells G, Suarez-Almazor ME. Injectable gold for rheumatoid arthritis. Cochrane Database Syst Rev 2000, 2:CD000520.
5. Thakor AS, Jokerst J, Zavaleta C, Massoud TF, Gambhir SS. Gold nanoparticles: a revival in precious metal administration to patients. Nano Lett 2011, 11:4029-4036.
6. Monteiro-Riviere NA, Inman AO. Challenges for assessing carbon nanomaterial toxicity to the skin. Carbon 2006, 44:1070-1078.
7. Monteiro-Riviere NA, Inman AO, Zhang LW. Limitations and relative utility of screening assays to assess engineered nanoparticle toxicity in a human cell line. Toxicol Appl Pharmacol 2009, 234:222-235.
8. Elsaesser A, Taylor A, de Yanés GS, McKerr G, Kim E-M, O'Hare E, Howard CV. Quantification of nanoparticle uptake by cells using microscopical and analytical techniques. Nanomedicine (Lond) 2010, 5:1447-1457.
9. Sasidharan A, Panchakarla LS, Sadanandan AR, Ashokan A, Chandran P, Girish CM, Menon D, Nair SV, Rao CN, Koyakutty M. Hemocompatibility and macrophage response of pristine and functionalized graphene. Small 2012, 8:1251-1263.
10. Sasidharan A, Panchakarla LS, Chandran P, Menon D, Nair S, Rao CNR, Koyakutty M. Differential nano-bio interactions and toxicity effects of pristine versus functionalized graphene. Nanoscale 2011, 3:2461-2464.
11. Tay CY, Setyawati MI, Xie J, Parak WJ, Leong DT. Back to basics: exploiting the innate physico-chemical characteristics of nanomaterials for biomedical applications. Adv Funct Mater 2014, 24:5936-5955.
12. Chithrani BD, Ghazani AA, Chan WCW. Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. Nano Lett 2006, 6:662-668.
13. Jiang W, Kim BYS, Rutka JT, Chan WCW. Nanoparticle-mediated cellular response is size-dependent. Nat Nanotechnol 2008, 3:145-150.
14. Nair S, Sasidharan A, Divya Rani VV, Menon D, Nair S, Manzoor K, Raina S. Role of size scale of ZnO nanoparticles and microparticles on toxicity toward bacteria and osteoblast cancer cells. J Mater Sci Mater Med 2009, 20:S235-S241.
15. Sasidharan A, Chandran P, Menon D, Raman S, Nair S, Koyakutty M. Rapid dissolution of ZnO nanocrystals in acidic cancer microenvironment leading to preferential apoptosis. Nanoscale 2011, 3:3657-3669.
16. Kim B, Han G, Toley BJ, Kim C-K, Rotello VM, Forbes NS. Tuning payload delivery in tumour cylindroids using gold nanoparticles. Nat Nanotechnol 2010, 5:465-472.
17. Goodman CM, McCusker CD, Yilmaz T, Rotello VM. Toxicity of gold nanoparticles functionalized with cationic and anionic side chains. Bioconjug Chem 2004, 15:897-900.
18. Sabella S, Brunetti V, Vecchio G, Galeone A, Maiorano G, Cingolani R, Pompa P. Toxicity of citrate-capped AuNPs: an in vitro and in vivo assessment. J Nanopart Res 2011, 13:6821-6835.
19. Lynch I, Dawson KA. Protein-nanoparticle interactions. Nano Today 2008, 3:40-47.
20. Walkey CD, Olsen JB, Song F, Liu R, Guo H, Olsen DWH, Cohen Y, Emili A, Chan WCW. Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles. ACS Nano 2014, 8:2439-2455.
21. Monteiro-Riviere NA, Samberg ME, Oldenburg SJ, Riviere JE. Protein binding modulates the cellular uptake of silver nanoparticles into human cells: implications for in vitro to in vivo extrapolations? Toxicol Lett 2013, 220:286-293.
22. Sasidharan A, Riviere JE, Monteiro-Riviere NA. Gold and silver nanoparticle interactions with human proteins: impact and implications in biocorona formation. J Mater Chem B 2015, 3:2075-2082.
23. Alkilany AM, Nagaria PK, Hexel CR, Shaw TJ, Murphy CJ, Wyatt MD. Cellular uptake and cytotoxicity of gold nanorods: molecular origin of cytotoxicity and surface effects. Small 2009, 5:701-708.
24. Pan Y, Leifert A, Ruau D, Neuss S, Bornemann J, Schmid G, Brandau W, Simon U, Jahnen-Dechent W. Gold nanoparticles of diameter 1.4 nm trigger necrosis by oxidative stress and mitochondrial damage. Small 2009, 5:2067-2076.
25. Liu Y, Meyer-Zaika W, Franzka S, Schmid G, Tsoli M, Kuhn H. Gold-cluster degradation by the transition of B-DNA into A-DNA and the formation of nanowires. Angew Chem Int Ed Engl 2003, 42:2853-2857.
26. Pan Y, Neuss S, Leifert A, Fischler M, Wen F, Simon U, Schmid G, Brandau W, Jahnen-Dechent W. Size-dependent cytotoxicity of gold nanoparticles. Small 2007, 3:1941-1949.
27. Zhang J, Nie X, Ji Y, Liu Y, Wu X, Chen C, Fang X. Quantitative biokinetics and systemic translocation of various gold nanostructures are highly dependent on their size and shape. J Nanosci Nanotechnol 2014, 14:4124-4138.
28. Alkilany AM, Murphy CJ. Toxicity and cellular uptake of gold nanoparticles: what we have learned so far? J Nanopart Res 2010, 12:2313-2333.
29. Connor EE, Mwamuka J, Gole A, Murphy CJ, Wyatt MD. Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity. Small 2005, 1:325-327.
30. Lin Z, Monteiro-Riviere NA, Riviere JE. Pharmacokinetics of metallic nanoparticles. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2015, 7:189-217.
31. Chen Y-S, Hung Y-C, Liau I, Huang GS. Assessment of the in vivo toxicity of gold nanoparticles. Nanoscale Res Lett 2009, 4:858-864.
32. Cho W-S, Cho M, Jeong J, Choi M, Cho H-Y, Han BS, Kim SH, Kim HO, Lim YT, Chung BH, et al. Acute toxicity and pharmacokinetics of 13 nm-sized PEG-coated gold nanoparticles. Toxicol Appl Pharmacol 2009, 236:16-24.
33. Cho W-S, Kim S, Han BS, Son WC, Jeong J. Comparison of gene expression profiles in mice liver following intravenous injection of 4 and 100 nm-sized PEG-coated gold nanoparticles. Toxicol Lett 2009, 191:96-102.
34. Lasagna-Reeves C, Gonzalez-Romero D, Barria MA, Olmedo I, Clos A, Sadagopa Ramanujam VM, Urayama A, Vergara L, Kogan MJ, Soto C. Bioaccumulation and toxicity of gold nanoparticles after repeated administration in mice. Biochem Biophys Res Commun 2010, 393:649-655.
35. Longmire M, Choyke PL, Kobayashi H. Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats. Nanomedicine (Lond) 2008, 3:703-717.
36. Choi HS, Liu W, Misra P, Tanaka E, Zimmer JP, Itty Ipe B, Bawendi MG, Frangioni JV. Renal clearance of quantum dots. Nat Biotechnol 2007, 25:1165-1170.
37. Semmler-Behnke M, Kreyling WG, Lipka J, Fertsch S, Wenk A, Takenaka S, Schmid G, Brandau W. Biodistribution of 1.4- and 18-nm gold particles in rats. Small 2008, 4:2108-2111.
38. Knop K, Hoogenboom R, Fischer D, Schubert US. Poly(ethylene glycol) in drug delivery: pros and cons as well as potential alternatives. Angew Chem Int Ed Engl 2010, 49:6288-6308.
39. Cho W-S, Cho M, Jeong J, Choi M, Han BS, Shin H-S, Hong J, Chung BH, Jeong J, Cho M-H. Size-dependent tissue kinetics of PEG-coated gold nanoparticles. Toxicol Appl Pharmacol 2010, 245:116-123.
40. Merchant B. Gold, the noble metal and the paradoxes of its toxicology. Biologicals 1998, 26:49-59.
41. Pricker SP. Medical uses of gold compounds: past, present and future. Gold Bull 1996, 29:53-60.
42. Gottlieb NL. Comparison of the kinetics of parenteral and oral gold. Scand J Rheumatol Suppl 1983, 51:10-14.
43. Seaman WB, Powers WE. Studies on the distribution of radioactive colloidal gold in regional lymph nodes containing cancer. Cancer 1955, 8:1044-1046.
44. Xia Y, Li W, Cobley CM, Chen J, Xia X, Zhang Q, Yang M, Cho EC, Brown PK. Gold nanocages: from synthesis to theranostic applications. Acc Chem Res 2011, 44:914-924.
45. Melancon MP, Lu W, Yang Z, Zhang R, Cheng Z, Elliot AM, Stafford J, Olson T, Zhang JZ, Li C. In vitro and in vivo targeting of hollow gold nanoshells directed at epidermal growth factor receptor for photothermal ablation therapy. Mol Cancer Ther 2008, 7:1730-1739.
46. Li J-L, Wang L, Liu X-Y, Zhang Z-P, Guo H-C, Liu W-M, Tang S-H. In vitro cancer cell imaging and therapy using transferrin-conjugated gold nanoparticles. Cancer Lett 2009, 274:319-326.
47. Hu R, Yong K-T, Roy I, Ding H, He S, Prasad PN. Metallic nanostructures as localized plasmon resonance enhanced scattering probes for multiplex dark field targeted imaging of cancer cells. J Phys Chem C 2009, 113:2676-2684.
48. Palmal S, Jana NR. Gold nanoclusters with enhanced tunable fluorescence as bioimaging probes. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2014, 6:102-110.
49. Wu X, He X, Wang K, Xie C, Zhou B, Qing Z. Ultrasmall near-infrared gold nanoclusters for tumor fluorescence imaging in vivo. Nanoscale 2010, 2:2244-2249.
50. Retnakumari A, Jayasimhan J, Chandran P, Menon D, Nair S, Mony U, Koyakutty M. CD33 monoclonal antibody conjugated Au cluster nano-bioprobe for targeted flow-cytometric detection of acute myeloid leukaemia. Nanotechnology 2011, 22:285102.
51. Retnakumari A, Setua S, Menon D, Ravindran P, Muhammed H, Pradeep T, Nair S, Koyakutty M. Molecular-receptor-specific, non-toxic, near-infrared-emitting Au cluster-protein nanoconjugates for targeted cancer imaging. Nanotechnology 2010, 21:055103.
52. Karmani L, Labar D, Valembois V, Bouchat V, Nagaswaran PG, Bol A, Gillart J, Levêque P, Bouzin C, Bonifazi D, et al. Antibody-functionalized nanoparticles for imaging cancer: influence of conjugation to gold nanoparticles on the biodistribution of 89Zr-labeled cetuximab in mice. Contrast Media Mol Imaging 2013, 8:402-408.
53. Xie H, Wang ZJ, Bao A, Goins B, Phillips WT. In vivo PET imaging and biodistribution of radiolabeled gold nanoshells in rats with tumor xenografts. Int J Pharm 2010, 395:324-330.
54. Wang Y, Liu Y, Luehmann H, Xia X, Brown P, Jarreau C, Welch M, Xia Y. Evaluating the pharmacokinetics and in vivo cancer targeting capability of Au nanocages by positron emission tomography imaging. ACS Nano 2012, 6:5880-5888.
55. Yang M, Cheng K, Qi S, Liu H, Jiang Y, Jiang H, Li J, Chen K, Zhang H, Cheng Z. Affibody modified and radiolabeled gold-iron oxide hetero-nanostructures for tumor PET, optical and MR imaging. Biomaterials 2013, 34:2796-2806.
56. Xiao Y, Hong H, Matson VZ, Javadi A, Xu W, Yang Y, Zhang Y, Engle JW, Nickles RJ, Cai W, et al. Gold nanorods conjugated with doxorubicin and cRGD for combined anticancer drug delivery and PET imaging. Theranostics 2012, 2:757-768.
57. Hainfeld JF, Slatkin DN, Focella TM, Smilowitz HM. Gold nanoparticles: a new X-ray contrast agent. Br J Radiol 2006, 79:248-253.
58. Kim D, Park S, Lee JH, Jeong YY, Jon S. Antibiofouling polymer-coated gold nanoparticles as a contrast agent for in vivo X-ray computed tomography imaging. J Am Chem Soc 2007, 129:7661-7665.
59. Bardhan R, Chen W, Bartels M, Perez-Torres C, Botero MF, McAninch RW, Contreras A, Schiff R, Pautler RG, Halas NJ, et al. Tracking of multimodal therapeutic nanocomplexes targeting breast cancer in vivo. Nano Lett 2010, 10:4920-4928.
60. Singhal S, Nie S, Wang MD. Nanotechnology applications in surgical oncology. Annu Rev Med 2010, 61:359-373.
61. Wilson AJ, Willets KA. Surface-enhanced Raman scattering imaging using noble metal nanoparticles. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2013, 5:180-189.
62. Qian X, Peng X-H, Ansari DO, Yin-Goen Q, Chen GZ, Shin DM, Yang L, Young AN, Wang MD, Nie S. In vivo tumor targeting and spectroscopic detection with surface-enhanced Raman nanoparticle tags. Nat Biotechnol 2008, 26:83-90.
63. Thakor AS, Luong R, Paulmurugan R, Lin FI, Kempen P, Zavaleta C, Chu P, Massoud TF, Sinclair R, Gambhir SS. The fate and toxicity of Raman-active silica-gold nanoparticles in mice. Sci Transl Med 2011, 3:79ra33.
64. Howes PD, Chandrawati R, Stevens MM. Colloidal nanoparticles as advanced biological sensors. Science 2014, 346:1247390.
65. Holzinger M, Le Goff A, Cosnier S. Nanomaterials for biosensing applications: a review. Front Chem 2014, 2:63.
66. Saha K, Agasti SS, Kim C, Li X, Rotello VM. Gold nanoparticles in chemical and biological sensing. Chem Rev 2012, 112:2739-2779.
67. Sperling RA, Rivera Gil P, Zhang F, Zanella M, Parak WJ. Biological applications of gold nanoparticles. Chem Soc Rev 2008, 37:1896-1908.
68. Li Y, Schluesener HJ, Xu S. Gold nanoparticle-based biosensors. Gold Bull 2010, 43:29-41.
69. Park S-J, Taton TA, Mirkin CA. Array-based electrical detection of DNA with nanoparticle probes. Science 2002, 295:1503-1506.
70. Mirkin CA, Letsinger RL, Mucic RC, Storhoff JJ. A DNA-based method for rationally assembling nanoparticles into macroscopic materials. Nature 1996, 382:607-609.
71. Wang Z, Lévy R, Fernig DG, Brust M. Kinase-catalyzed modification of gold nanoparticles: a new approach to colorimetric kinase activity screening. J Am Chem Soc 2006, 128:2214-2215.
72. Nath N, Chilkoti A. A colorimetric gold nanoparticle sensor to interrogate biomolecular interactions in real time on a surface. Anal Chem 2002, 74:504-509.
73. Lin C-C, Yang Y-M, Chen Y-F, Yang T-S, Chang H-C. A new protein A assay based on Raman reporter labeled immunogold nanoparticles. Biosens Bioelectron 2008, 24:178-183.
74. Cao YC, Jin R, Mirkin CA. Nanoparticles with Raman spectroscopic fingerprints for DNA and RNA detection. Science 2002, 297:1536-1540.
75. Xiao Y, Patolsky F, Katz E, Hainfeld JF, Willner I. "Plugging into enzymes": nanowiring of redox enzymes by a gold nanoparticle. Science 2003, 299:1877-1881.
76. Xu Q, Mao C, Liu N-N, Zhu J-J, Sheng J. Direct electrochemistry of horseradish peroxidase based on biocompatible carboxymethyl chitosan-gold nanoparticle nanocomposite. Biosens Bioelectron 2006, 22:768-773.
77. Andreescu S, Luck LA. Studies of the binding and signaling of surface-immobilized periplasmic glucose receptors on gold nanoparticles: a glucose biosensor application. Anal Biochem 2008, 375:282-290.
78. Lin L, Zhao H, Li J, Tang J, Duan M, Jiang L. Study on colloidal Au-enhanced DNA sensing by quartz crystal microbalance. Biochem Biophys Res Commun 2000, 274:817-820.
79. Liu T, Tang JA, Jiang L. Sensitivity enhancement of DNA sensors by nanogold surface modification. Biochem Biophys Res Commun 2002, 295:14-16.
80. Pang L, Li J, Jiang J, Shen G, Yu R. DNA point mutation detection based on DNA ligase reaction and nano-Au amplification: a piezoelectric approach. Anal Biochem 2006, 358:99-103.
81. Zhang Y, Wang H, Yan B, Zhang Y, Li J, Shen G, Yu R. A reusable piezoelectric immunosensor using antibody-adsorbed magnetic nanocomposite. J Immunol Methods 2008, 332:103-111.
82. Tiwari P, Vig K, Dennis V, Singh S. Functionalized gold nanoparticles and their biomedical applications. Nanomaterials 2011, 1:31-63.
83. Sabella S. Impact of bionanointeractions of engineered nanoparticles for nanomedicine. In: Monteiro-Riviere NA, Tran CL, eds. Nanotoxicology: Progress Toward Nanomedicine. 2nd ed. Boca Raton, FL: CRC Press; 2014, 21-36.
84. Alkilany AM, Frey RL, Ferry JL, Murphy CJ. Gold nanorods as nanoadmicelles: 1-naphthol partitioning into a nanorod-bound surfactant bilayer. Langmuir 2008, 24:10235-10239.
85. Kim CK, Ghosh P, Pagliuca C, Zhu Z-J, Menichetti S, Rotello VM. Entrapment of hydrophobic drugs in nanoparticle monolayers with efficient release into cancer cells. J Am Chem Soc 2009, 131:1360-1361.
86. Cao-Milán R, Liz-Marzán LM. Gold nanoparticle conjugates: recent advances toward clinical applications. Expert Opin Drug Deliv 2014, 11:741-752.
87. Rojo J, Díaz V, de la Fuente JM, Segura I, Barrientos AG, Riese HH, Bernad A, Penadés S. Gold glyconanoparticles as new tools in antiadhesive therapy. Chembiochem 2004, 5:291-297.
88. Sandhu KK, McIntosh CM, Simard JM, Smith SW, Rotello VM. Gold nanoparticle-mediated transfection of mammalian cells. Bioconjug Chem 2002, 13:3-6.
89. Thomas M, Klibanov AM. Conjugation to gold nanoparticles enhances polyethylenimine's transfer of plasmid DNA into mammalian cells. Proc Natl Acad Sci USA 2003, 100:9138-9143.
90. Oishi M, Nakaogami J, Ishii T, Nagasaki Y. Smart PEGylated gold nanoparticles for the cytoplasmic delivery of siRNA to induce enhanced gene silencing. Chem Lett 2006, 35:1046-1047.
91. Mukherjee P, Bhattacharya R, Wang P, Wang L, Basu S, Nagy JA, Atala A, Mukhopadhyay D, Soker S. Antiangiogenic properties of gold nanoparticles. Clin Cancer Res 2005, 11:3530-3534.
92. Dreaden EC, Mwakwari SC, Sodji QH, Oyelere AK, El-Sayed MA. Tamoxifen-poly(ethylene glycol)-thiol gold nanoparticle conjugates: enhanced potency and selective delivery for breast cancer treatment. Bioconjug Chem 2009, 20:2247-2253.
93. Brown SD, Nativo P, Smith J-A, Stirling D, Edwards PR, Venugopal B, Flint DJ, Plumb JA, Graham D, Wheate NJ. Gold nanoparticles for the improved anticancer drug delivery of the active component of oxaliplatin. J Am Chem Soc 2010, 132:4678-4684.
94. Agasti SS, Chompoosor A, You C-C, Ghosh P, Kim CK, Rotello VM. Photoregulated release of caged anticancer drugs from gold nanoparticles. J Am Chem Soc 2009, 131:5728-5729.
95. Yavuz MS, Cheng Y, Chen J, Cobley CM, Zhang Q, Rycenga M, Xie J, Kim C, Song KH, Schwartz AG, et al. Gold nanocages covered by smart polymers for controlled release with near-infrared light. Nat Mater 2009, 8:935-939.
96. Yang X-C, Samanta B, Agasti SS, Jeong Y, Zhu Z-J, Rana S, Miranda OR, Rotello VM. Drug delivery using nanoparticle-stabilized nanocapsules. Angew Chem Int Ed Engl 2011, 50:477-481.
97. Jin Y, Gao X. Spectrally tunable leakage-free gold nanocontainers. J Am Chem Soc 2009, 131:17774-17776.
98. van der Zee J. Heating the patient: a promising approach? Ann Oncol 2002, 13:1173-1184.
99. Chu KF, Dupuy DE. Thermal ablation of tumours: biological mechanisms and advances in therapy. Nat Rev Cancer 2014, 14:199-208.
100. Hirsch LR, Stafford RJ, Bankson JA, Sershen SR, Rivera B, Price RE, Hazle JD, Halas NJ, West JL. Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance. Proc Natl Acad Sci USA 2003, 100:13549-13554.
101. Huang X, Qian W, El-Sayed IH, El-Sayed MA. The potential use of the enhanced nonlinear properties of gold nanospheres in photothermal cancer therapy. Lasers Surg Med 2007, 39:747-753.
102. Bernardi RJ, Lowery AR, Thompson PA, Blaney SM, West JL. Immunonanoshells for targeted photothermal ablation in medulloblastoma and glioma: an in vitro evaluation using human cell lines. J Neurooncol 2008, 86:165-172.
103. Carpin LB, Bickford LR, Agollah G, Yu T-K, Schiff R, Li Y, Drezek RA. Immunoconjugated gold nanoshell-mediated photothermal ablation of trastuzumab-resistant breast cancer cells. Breast Cancer Res Treat 2011, 125:27-34.
104. Van de Broek B, Devoogdt N, D'Hollander A, Gijs H-L, Jans K, Lagae L, Muyldermans S, Maes G, Borghs G. Specific cell targeting with nanobody conjugated branched gold nanoparticles for photothermal therapy. ACS Nano 2011, 5:4319-4328.
105. Qu X, Yao C, Wang J, Li Z, Zhang Z. Anti-CD30-targeted gold nanoparticles for photothermal therapy of L-428 Hodgkin's cell. Int J Nanomedicine 2012, 7:6095-6103.
106. Hauck TS, Jennings TL, Yatsenko T, Kumaradas JC, Chan WCW. Enhancing the toxicity of cancer chemotherapeutics with gold nanorod hyperthermia. Adv Mater 2008, 20:3832-3838.
107. Park H, Yang J, Lee J, Haam S, Choi I-H, Yoo K-H. Multifunctional nanoparticles for combined doxorubicin and photothermal treatments. ACS Nano 2009, 3:2919-2926.
108. Ren F, Bhana S, Norman DD, Johnson J, Xu L, Baker DL, Parrill AL, Huang X. Gold nanorods carrying paclitaxel for photothermal-chemotherapy of cancer. Bioconjug Chem 2013, 24:376-386.
109. Song J, Pu L, Zhou J, Duan B, Duan H. Biodegradable theranostic plasmonic vesicles of amphiphilic gold nanorods. ACS Nano 2013, 7:9947-9960.
110. Shao J, Griffin RJ, Galanzha EI, Kim J-W, Koonce N, Webber J, Mustafa T, Biris AS, Nedosekin DA, Zharov VP. Photothermal nanodrugs: potential of TNF-gold nanospheres for cancer theranostics. Sci Rep 2013, 3:1293.
111. You J-O, Guo P, Auguste DT. A drug-delivery vehicle combining the targeting and thermal ablation of HER2+ breast-cancer cells with triggered drug release. Angew Chem Int Ed Engl 2013, 52:4141-4146.
112. Timko BP, Dvir T, Kohane DS. Remotely triggerable drug delivery systems. Adv Mater 2010, 22:4925-4943.
113. Lee S-M, Park H, Yoo K-H. Synergistic cancer therapeutic effects of locally delivered drug and heat using multifunctional nanoparticles. Adv Mater 2010, 22:4049-4053.
114. Glazer ES, Curley SA. Non-invasive radiofrequency ablation of malignancies mediated by quantum dots, gold nanoparticles and carbon nanotubes. Ther Deliv 2011, 2:1325-1330.
115. McGhana JP, Dodd GD. Radiofrequency ablation of the liver: current status. AJR Am J Roentgenol 2001, 176:3-16.
116. Sasidharan A, Sivaram AJ, Retnakumari AP, Chandran P, Malarvizhi GL, Nair S, Koyakutty M. Radiofrequency ablation of drug-resistant cancer cells using molecularly targeted carboxyl-functionalized biodegradable graphene. Adv Healthc Mater 2015. doi:10.1002/adhm.201400670.
117. Cardinal J, Klune JR, Chory E, Jeyabalan G, Kanzius JS, Nalesnik M, Geller DA. Noninvasive radiofrequency ablation of cancer targeted by gold nanoparticles. Surgery 2008, 144:125-132.
118. Glazer ES, Zhu C, Massey KL, Thompson CS, Kaluarachchi WD, Hamir AN, Curley SA. Noninvasive radiofrequency field destruction of pancreatic adenocarcinoma xenografts treated with targeted gold nanoparticles. Clin Cancer Res 2010, 16:5712-5721.
119. Glazer ES, Massey KL, Zhu C, Curley SA. Pancreatic carcinoma cells are susceptible to noninvasive radio frequency fields after treatment with targeted gold nanoparticles. Surgery 2010, 148:319-324.
120. Raoof M, Curley SA. Non-invasive radiofrequency-induced targeted hyperthermia for the treatment of hepatocellular carcinoma. Int J Hepatol 2011, 2011:676957.
121. Chatterjee DK, Fong LS, Zhang Y. Nanoparticles in photodynamic therapy: an emerging paradigm. Adv Drug Deliv Rev 2008, 60:1627-1637.
122. Triesscheijn M, Baas P, Schellens JHM, Stewart FA. Photodynamic therapy in oncology. Oncologist 2006, 11:1034-1044.
123. Dolmans DEJGJ, Fukumura D, Jain RK. Photodynamic therapy for cancer. Nat Rev Cancer 2003, 3:380-387.
124. Bardhan R, Grady NK, Cole JR, Joshi A, Halas NJ. Fluorescence enhancement by Au nanostructures: nanoshells and nanorods. ACS Nano 2009, 3:744-752.
125. Shiotani A, Mori T, Niidome T, Niidome Y, Katayama Y. Stable incorporation of gold nanorods into N-isopropylacrylamide hydrogels and their rapid shrinkage induced by near-infrared laser irradiation. Langmuir 2007, 23:4012-4018.
126. Sershen SR, Westcott SL, Halas NJ, West JL. Temperature-sensitive polymer-nanoshell composites for photothermally modulated drug delivery. J Biomed Mater Res 2000, 51:293-298.
127. Stuchinskaya T, Moreno M, Cook MJ, Edwards DR, Russell DA. Targeted photodynamic therapy of breast cancer cells using antibody-phthalocyanine-gold nanoparticle conjugates. Photochem Photobiol Sci 2011, 10:822-831.
128. Oo MKK, Yang X, Du H, Wang H. 5-aminolevulinic acid-conjugated gold nanoparticles for photodynamic therapy of cancer. Nanomedicine (Lond) 2008, 3:777-786.
129. Chang J-E, Yoon I-S, Sun P-L, Yi E, Jheon S, Shim C-K. Anticancer efficacy of photodynamic therapy with hematoporphyrin-modified, doxorubicin-loaded nanoparticles in liver cancer. J Photochem Photobiol B 2014, 140:49-56.
130. Vankayala R, Lin C-C, Kalluru P, Chiang C-S, Hwang KC. Gold nanoshells-mediated bimodal photodynamic and photothermal cancer treatment using ultra-low doses of near infra-red light. Biomaterials 2014, 35:5527-5538.
131. Webb JA, Bardhan R. Emerging advances in nanomedicine with engineered gold nanostructures. Nanoscale 2014, 6:2502-2530.
132. Murphy CJ, Gole AM, Stone JW, Sisco PN, Alkilany AM, Goldsmith EC, Baxter SC. Gold nanoparticles in biology: beyond toxicity to cellular imaging. Acc Chem Res 2008, 41:1721-1730.
133. Dreaden EC, Alkilany AM, Huang X, Murphy CJ, El-Sayed MA. The golden age: gold nanoparticles for biomedicine. Chem Soc Rev 2012, 41:2740-2779.
134. Dykman L, Khlebtsov N. Gold nanoparticles in biomedical applications: recent advances and perspectives. Chem Soc Rev 2012, 41:2256-2282.
135. Alkilany AM, Murphy CJ. Toxicity and cellular uptake of gold nanoparticles: what we have learned so far? J Nanopart Res 2010, 12:2313-2333.
136. Alkilany AM, Nagaria PK, Hexel CR, Shaw TJ, Murphy CJ, Wyatt MD. Cellular uptake and cytotoxicity of gold nanorods: molecular origin of cytotoxicity and surface effects. Small 2009, 5:701-708.
137. Khlebtsov N, Dykman L. Biodistribution and toxicity of engineered gold nanoparticles: a review of in vitro and in vivo studies. Chem Soc Rev 2011, 40:1647-1671.
138. Cai W, Gao T, Hong H, Sun J. Applications of gold nanoparticles in cancer nanotechnology. Nanotechnol Sci Appl 2008, 1:17-32.
139. Chen LY, Wang CW, Yuan Z, Chang HT. Fluorescent gold nanoclusters: recent advances in sensing and imaging. Anal Chem 2015, 87:216-229.
140. Giljohann DA, Seferos DS, Daniel WL, Massich MD, Patel PC, Mirkin CA. Gold nanoparticles for biology and medicine. Angew Chem Int Ed Engl 2010, 49:3280-3294.